Miraxion

Ethyl-EPA · Amarin Neuroscience Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Miraxion, covering 2007-12-27 to 2007-12-27. Get the full timeline:

Most recent: Clinical Trial Update: TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease [Phase 3]